The Shift Towards Molecular and Component-Resolved Diagnostic Testing The next frontier in the pet allergy market lies in diagnostic refinement, specifically moving beyond whole-allergen extracts to Molecular Component-Resolved Diagnostics (mCRD). This advanced technology tests for specific protein components within an allergen, providing a much more precise picture of which components are...